Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2016 On November 4, 2015

Oct 26, 2015, 16:11 ET from Array BioPharma Inc.

BOULDER, Colo., Oct. 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will report financial results for the first quarter of fiscal 2016 and hold a conference call to discuss those results on Wednesday, November 4, 2015.  Ron Squarer, Chief Executive Officer, and Pat Henahan, Chief Financial Officer, will lead the call.

 

Date:

Wednesday, November 4, 2015

Time:

9:00 a.m. Eastern Time

Toll-Free:

(844) 464-3927

Toll:

(765) 507-2598

Pass Code:

52112326

Webcast, including Replay and Conference Call Slides:

http://edge.media-server.com/m/p/jrd7v7xa/lan/en

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com
http://www.arraybiopharma.com